{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:12:40Z","timestamp":1791198760973,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.yexmp.2017.01.012","type":"journal-article","created":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T03:30:27Z","timestamp":1484364627000},"page":"156-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Spectrum of mutations in leiomyosarcomas identified by clinical targeted next-generation sequencing"],"prefix":"10.1016","volume":"102","author":[{"given":"Paul J","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi S.","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian S.","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine E","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley J","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J","family":"Duncavage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7422","key":"10.1016\/j.yexmp.2017.01.012_bb0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes","volume":"491","author":"1000 Genomes Project Consortium","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.yexmp.2017.01.012_bb0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ng.619","article-title":"Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy","volume":"42","author":"Barretina","year":"2010","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.yexmp.2017.01.012_bb0015","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/onc.2009.381","article-title":"Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling","volume":"29","author":"Beck","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.yexmp.2017.01.012_bb0020","first-page":"519","article-title":"An update on PARP inhibitors for treatment of cancer","volume":"8","author":"Benafif","year":"2015","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.yexmp.2017.01.012_bb0025","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.5858\/2006-130-1448-GOSTSR","article-title":"Grading of soft tissue sarcomas: review and update","volume":"130","author":"Coindre","year":"2006","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"2","key":"10.1016\/j.yexmp.2017.01.012_bb0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/labinvest.3780229","article-title":"Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas","volume":"81","author":"Derre","year":"2001","journal-title":"Lab. Investig."},{"issue":"3","key":"10.1016\/j.yexmp.2017.01.012_bb0035","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0002-9440(10)65640-4","article-title":"DNA copy number changes in development and progression in leiomyosarcomas of soft tissues","volume":"153","author":"El-Rifai","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexmp.2017.01.012_bb0040","author":"Exome Variant Server","year":"2014"},{"key":"10.1016\/j.yexmp.2017.01.012_bb0045","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone","first-page":"131","article-title":"Smooth Muscle Tumor","author":"Fletcher","year":"2013"},{"issue":"6219","key":"10.1016\/j.yexmp.2017.01.012_bb0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1126\/science.1257216","article-title":"Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors","volume":"347","author":"Flynn","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.yexmp.2017.01.012_bb0055","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.yexmp.2017.01.012_bb0060","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygyno.2011.10.019","article-title":"Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma","volume":"124","author":"Francis","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexmp.2017.01.012_bb0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/path.2787","article-title":"New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics","volume":"223","author":"Gibault","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexmp.2017.01.012_bb0070","series-title":"Enzinger & Weiss's Soft Tissue Tumors","first-page":"549","article-title":"Leiomyosarcoma","author":"Goldblum","year":"2014"},{"key":"10.1016\/j.yexmp.2017.01.012_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/380896","article-title":"Classification, molecular characterization, and the significance of Pten alterations in leiomyosaromas","author":"Grossman","year":"2012","journal-title":"Sarcoma"},{"key":"10.1016\/j.yexmp.2017.01.012_bb0080","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00428-009-0853-4","article-title":"Soft tissue sarcomas with complex genomic profiles","volume":"456","author":"Guillou","year":"2010","journal-title":"Virchows Arch."},{"issue":"1","key":"10.1016\/j.yexmp.2017.01.012_bb0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1097-0142(19920701)70:1<114::AID-CNCR2820700119>3.0.CO;2-U","article-title":"Soft tissue leiomyosarcoma a population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content","volume":"70","author":"Gustafson","year":"1992","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.yexmp.2017.01.012_bb0090","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/1097-0142(19860515)57:10<2077::AID-CNCR2820571033>3.0.CO;2-T","article-title":"Leiomyosarcoma of the external soft tissues a clinicopathologic, immunohistochemical, and electron microscopic study","volume":"57","author":"Hashimoto","year":"1986","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.yexmp.2017.01.012_bb0095","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1560","article-title":"The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas","volume":"13","author":"Hernando","year":"2007","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.yexmp.2017.01.012_bb0100","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/MCB.25.2.661-670.2005","article-title":"Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression","volume":"35","author":"Kang","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.yexmp.2017.01.012_bb0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cancergencyto.2006.01.008","article-title":"Gene copy number profiling of soft-tissue leiomyosarcomas by array-comparative genomic hybridization","volume":"169","author":"Larramendy","year":"2006","journal-title":"Cancer Genet. Cytogenet."},{"issue":"2","key":"10.1016\/j.yexmp.2017.01.012_bb0110","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/PAS.0000000000000324","article-title":"Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome","volume":"39","author":"Liau","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.yexmp.2017.01.012_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005850","article-title":"Exome sequencing of uterine leiomyosarcomas identifies frequent mutations in TP53, ATRX, MED12","volume":"12","author":"Makinen","year":"2016","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.yexmp.2017.01.012_bb0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1098-2264(199805)22:1<16::AID-GCC3>3.0.CO;2-A","article-title":"Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group","volume":"22","author":"Mertens","year":"1998","journal-title":"Genes Chromosom. Cancer"},{"issue":"4","key":"10.1016\/j.yexmp.2017.01.012_bb0125","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11912-007-0039-7","article-title":"The role of mTOR inhibitors for treatment of sarcomas","volume":"9","author":"Mita","year":"2007","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.yexmp.2017.01.012_bb0130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2559.2002.01361.x","article-title":"Clinicopathological prognostic factors in soft tissue leiomyosarcoma: a multivariate analysis","volume":"40","author":"Miyajima","year":"2002","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.yexmp.2017.01.012_bb0135","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0046-8177(95)90136-1","article-title":"p53 protein overexpression in smooth muscle tumors of the uterus","volume":"26","author":"Niemann","year":"1995","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yexmp.2017.01.012_bb0140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000015640","article-title":"Detection of chromosomal imbalances in leiomyosarcoma by comparative genomic hybridization and interphase cytogenetics","volume":"90","author":"Otano-Joos","year":"2000","journal-title":"Cytogenet. Cell Genet."},{"issue":"4","key":"10.1016\/j.yexmp.2017.01.012_bb0145","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.2353\/ajpath.2010.100104","article-title":"Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics","volume":"177","author":"P\u00e9rot","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexmp.2017.01.012_bb0150","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/modpathol.2012.203","article-title":"MED12 mutations in leiomyosarcoma and extrauterine leiomyoma","volume":"26","author":"Ravegnini","year":"2013","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.yexmp.2017.01.012_bb0155","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0046-8177(03)00014-5","article-title":"Gene expression analysis of human soft tissue leiomyosarcomas","volume":"34","author":"Ren","year":"2003","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yexmp.2017.01.012_bb0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/1040-8428(94)00144-I","article-title":"Epidermal growth factor-related peptides and their receptors in human malignancies","volume":"19","author":"Salomon","year":"1995","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.yexmp.2017.01.012_bb0165","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexmp.2017.01.012_bb0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.yexmp.2017.01.012_bb0175","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/cjp2.11","article-title":"Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumor of uncertain malignant potential and early stage uterine leiomyosarcoma","volume":"1","author":"Slatter","year":"2015","journal-title":"J. Pathol. Clin. Res."},{"issue":"5","key":"10.1016\/j.yexmp.2017.01.012_bb0180","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/ncb1571","article-title":"P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM","volume":"9","author":"Song","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yexmp.2017.01.012_bb0185","series-title":"Targeted Therapy in Oncology: Mechanisms and Toxicity","first-page":"35","article-title":"EGFR and ERBB2 expression in sarcomas: the search for new treatment options","author":"Steeghs","year":"2009"},{"key":"10.1016\/j.yexmp.2017.01.012_bb0190","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/bjc.1989.251","article-title":"Structural alterations of the RB1 gene in human soft tissue tumours","volume":"60","author":"Stratton","year":"1989","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.yexmp.2017.01.012_bb0195","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2613.2009.00680.x","article-title":"Common genetics changes in leiomyosarcoma and gastrointestinal stromal tumour: implications for ataxia telangiectasia mutated involvement","volume":"90","author":"UI-Hassan","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"issue":"4","key":"10.1016\/j.yexmp.2017.01.012_bb0200","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1158\/1078-0432.CCR-09-0787","article-title":"Targeting the RB-pathway in cancer therapy","volume":"16","author":"Wang","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.yexmp.2017.01.012_bb0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/gcc.1118","article-title":"Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis","volume":"31","author":"Wang","year":"2001","journal-title":"Genes Chromosom. Cancer"},{"issue":"6","key":"10.1016\/j.yexmp.2017.01.012_bb0210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00125480-200211000-00004","article-title":"Smooth muscle tumors of soft tissue","volume":"9","author":"Weiss","year":"2002","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.yexmp.2017.01.012_bb0215","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/1097-0142(19810815)48:4<1022::AID-CNCR2820480429>3.0.CO;2-5","article-title":"Leiomyosarcoma of soft tissue: a clinicopathologic study","volume":"48","author":"Wile","year":"1981","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.yexmp.2017.01.012_bb0220","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/MCB.15.5.2536","article-title":"In vivo association of E2F and DP family proteins","volume":"5","author":"Wu","year":"1995","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.yexmp.2017.01.012_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.06.013","article-title":"Genetic aberrations in soft tissue leiomyosarcoma","volume":"275","author":"Yang","year":"2009","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.yexmp.2017.01.012_bb0230","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1200\/JCO.2008.19.8366","article-title":"Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems","volume":"27","author":"Zivanovic","year":"2009","journal-title":"J. Clin. Oncol."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480016304361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480016304361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T14:49:04Z","timestamp":1658414944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480016304361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0014480016304361"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2017.01.012","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spectrum of mutations in leiomyosarcomas identified by clinical targeted next-generation sequencing","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2017.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}